Hollencrest Capital Management trimmed its stake in shares of iShares Dow Jones US Medical Dev. (BMV:IHI) by 2.1% during the first quarter, HoldingsChannel reports. The firm owned 30,786 shares of the company’s stock after selling 669 shares during the period. iShares Dow Jones US Medical Dev. comprises 1.0% of Hollencrest Capital Management’s holdings, making the stock its 18th biggest holding. Hollencrest Capital Management’s holdings in iShares Dow Jones US Medical Dev. were worth $7,128,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Cambridge Investment Research Advisors Inc. boosted its holdings in iShares Dow Jones US Medical Dev. by 41.5% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,869 shares of the company’s stock valued at $9,231,000 after purchasing an additional 11,687 shares in the last quarter. Gerber Kawasaki Wealth & Investment Management boosted its holdings in shares of iShares Dow Jones US Medical Dev. by 27.0% in the 1st quarter. Gerber Kawasaki Wealth & Investment Management now owns 13,740 shares of the company’s stock worth $3,181,000 after acquiring an additional 2,920 shares in the last quarter. Outlook Wealth Advisors LLC acquired a new position in shares of iShares Dow Jones US Medical Dev. in the 1st quarter worth approximately $1,206,000. Kovack Advisors Inc. boosted its holdings in shares of iShares Dow Jones US Medical Dev. by 26.2% in the 1st quarter. Kovack Advisors Inc. now owns 3,425 shares of the company’s stock worth $793,000 after acquiring an additional 710 shares in the last quarter. Finally, Moloney Securities Asset Management LLC boosted its holdings in shares of iShares Dow Jones US Medical Dev. by 278.3% in the 1st quarter. Moloney Securities Asset Management LLC now owns 4,892 shares of the company’s stock worth $1,133,000 after acquiring an additional 3,599 shares in the last quarter.

Shares of IHI opened at $220.30 on Wednesday. iShares Dow Jones US Medical Dev. has a one year low of $2,806.59 and a one year high of $3,563.30.

TRADEMARK VIOLATION NOTICE: “Hollencrest Capital Management Sells 669 Shares of iShares Dow Jones US Medical Dev. (IHI)” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.watchlistnews.com/hollencrest-capital-management-sells-669-shares-of-ishares-dow-jones-us-medical-dev-ihi/3018788.html.

Featured Article: How Do I Invest in Dividend Stocks

Want to see what other hedge funds are holding IHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Dow Jones US Medical Dev. (BMV:IHI).

Institutional Ownership by Quarter for iShares Dow Jones US Medical Dev. (BMV:IHI)

Receive News & Ratings for iShares Dow Jones US Medical Dev. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Dow Jones US Medical Dev. and related companies with MarketBeat.com's FREE daily email newsletter.